A decline in a combined category can conceal continued use of particular medicines.
Among 278 patients initially hospitalized with major depression, recorded benzodiazepine prescribing fell from 84.9% at baseline to 36.7% at three years. Some individual agents changed clearly over time while others did not. Related hypnotics were also analyzed.
The retrospective records lacked detailed dose information. Prescribing differs from ingestion, and the initial inpatient population is not representative of every person with depression. Combined-category labels require care because related hypnotics are chemically distinct.
Follow individual agents and doses rather than assuming everyone stopped when the group percentage declined. This study cannot establish abstinence, dependence or causation of symptoms in a particular patient. A reliable account needs longitudinal prescriptions, dispensing, actual use and clinical assessments.
Source: PMC12967086, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Diazepam Zoster-Pain Trial Showed Small Short-Term Score Differences.